Photo of Melissa D. Aldridge

Melissa D. Aldridge

  • ASSOCIATE PROFESSOR Geriatrics and Palliative Medicine
Print ProfilePrint Profile

Education

  • B.A., College of the Holy Cross

  • M.B.A., New York University, Leonard N. Stern School of Business

  • M.P.H., Columbia University, Joseph L. Mailman School of Public Health

  • Ph.D., Yale University Graduate School of Arts and Sciences
    Program in Health Policy and Administration

Biography

    Dr. Aldridge's research focuses on quality and access to healthcare services for patients with serious illness. Her body of work examines the impact of hospice ownership, size, and other organization-level features on the delivery of hospice care and access to hospice services. She has studied hospice admission policies and their potential impact on access to care for patients and families.  She has also examined variation across hospices in patient discharge rates and the impact that discharge from hospice has on patients and Medicare costs. Her formal research training includes a Ph.D. from Yale University with emphasis in health economics, health policy, and statistical methods in health services research.
    Dr. Aldridge is the recipient of a Brookdale Leadership in Aging Fellowship, an NPCRC junior faculty award, and an NIH Career Development Award. Her current projects include examining hospice preferred practices and their association with patient outcomes and hospice costs with the goal of disseminating this information to improve the quality of hospice care.

    http://directory.mssm.edu/faculty/facultyInfo.php?id=37791&deptid=14

Awards

  • 2011 -
    Junior Faculty Investigator Award
    American Academy of Hospice and Palliative Medicine

  • 2007 - 2009
    Brookdale Leadership in Aging Fellowship

Publications

Aldridge Carlson MD, Barry CL, Cherlin EJ, McCorkle R, Bradley EH. Hospices' Enrollment Policies May Contribute to Underuse of Hospice Care in the United States. Health Affairs 2012 December; 31(12): 2690-2698.

Kelley AS, Deb P, Du Q, Aldridge Carlson MD, Morrison RS. Hospice Enrollment Saves Money for Medicare and Improves Care Quality Across a Number of Different Lengths-of-Stay. . Health Affairs 2013; 32(3): 552-561.

Thompson JW, Carlson MD, Bradley EH. US Hospice Industry Experienced Considerable Turbulence From Changes In Ownership, Growth, And Shift To For-Profit Status. Health Affairs 2012 June; 31(6).

Barry CL, Carlson MD, Thompson JW, Schlesinger M, McCorkle R, Kasl SV, Bradley EH. Caring for grieving family members: results from a national hospice survey. Medical care 2012 Jul; 50(7).

Carlson MD, Barry C, Schlesinger M, McCorkle R, Morrison RS, Cherlin E, Herrin J, Thompson J, Twaddle ML, Bradley EH. Quality of palliative care at US hospices: results of a national survey. Medical care 2011 Sep; 49(9).

Carlson MD, Lim B, Meier DE. Strategies and innovative Models for Delivering Palliative Care in Nursing Homes. Journal of the American Medical Directors Association 2011; 12(-~): 91-98.

Carlson MD, Herrin J, Du Q, Epstein AJ, Barry CL, Morrison RS, Black AL, Bradley EH. Impact of Hospice Disenrollment on Healthcare Use and Medicare Expenditures for Patients with Cancer. Journal of Clinical Oncology 2010; 28(28): 4371-4375.

Legler A, Bradley EH, Carlson MD. The effect of comorbidity burden on health care utilization for patients with cancer using hospice. Journal of palliative medicine 2011 Jun; 14(6).

Carlson MD, Bradley EH, Du Q, Morrison RS. Geographic Access to Hospice in the United States. Journal of Palliative Medicine 2010; 13(11): 1331-1338.

Meier DE, Lim B, Carlson MD. Raising the Standard: Palliative Care in Nursing Homes. Health Affairs 2010; 29: 136-140.

Goldstein N, Carlson MD, Kutner J. Management of Implantable Defibrillators in Hospice: Results of a Nationwide Survey and Implications for Quality Improvement. Annals of Internal Medicine 2010; 152: 296-299.

Cherlin E, Carlson MD, Herrin J, Barry C, McCorkle R, Schulman-Green D, Bradley E. Interdisciplinary Staffing Patterns: Do For Profit and Nonprofit Hospices Differ?. Journal of Palliative Medicine 2010; 13(4): 389-394.

Schulman-Green D, Cherlin EJ, McCorckle R, Carlson MD, Pace KB, Neigh J, Hennessy M, Johnson-Hurzeler R, Bradley EH. Benefits and Challenges in Use of a Standardized Symptom Assessment Instrument in Hospice. Journal of Palliative Medicine 2010; 13(2): 155-159.

Carlson MD, Herrin J, Du Q, Cherlin EM, Morrison RS, Bradley EH. Hospice Characteristics and the Dis-Enrollment of Patients with Cancer. Health Services Research 2009; 44(6): 2004-2021.

Carlson MD, Morrison RS. Study Design, Precision, and Validity in Observational Studies. Journal of Palliative Medicine 2009; 12(1): 77-81.

Carlson MD, Morrison RS. User's Guide to Research in Palliative Care: Why is a New Series Needed?. Journal of Palliative Medicine 2009; 11(9): 1258-1261.

Carlson MD, Morrison RS, Bradley EH. Improving Access to Hospice Care: Informing the Debate. Journal of Palliative Medicine 2008; 11(3): 1258-1261.

Carlson MD, Schlesinger M, Holford T, Morrison RS, Bradley EH. Regulating Palliative Care: The Case of Hospice. Journal of Pain and Symptom Management 2008; 36(2): 107-116.

Bradley EH, Carlson MD, Gallo WT, Scinto J, Campbell MK, Krumholz HM. From adversary to partner: have quality improvement organizations made the transition?. Health Serv Res 2005 Apr; 40(2): 459-76.

Carlson MD, Gallo WT, Bradley EH. Ownership status and patterns of care in hospice: results from the National Home and Hospice Care Survey. Med Care 2004 May; 42(5): 432-8.

Carlson MD, Bradley EH, Holford T, Morrison RS. Hospice Care: What Services Do Patients and Their Families Receive? Health Services Research. Health Services Research 2007; 42(4): 1672-1690.

Morrison RS, Carlson MD. Evaluating Palliative Care Programs: Let's Do It Right. Journal of Palliative Medicine 2007; 10(1): 17-18.

Bradley EH, Prigerson H, Carlson MD, Cherlin E, Johnson-Hurzeler R, Kasl SV. Depression among surviving caregivers: does length of hospice enrollment matter?. Am J Psychiatry 2004 Dec; 161(12): 2257-62.

.;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Aldridge did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

19 East 98th Street Floor 8 Room 809
New York, NY 10029

Tel: 212-241-8994
Fax: 212-241-5960